|By Marketwired .||
|November 30, 2016 03:20 PM EST|
IRVINE, CA -- (Marketwired) -- 11/30/16 -- Central Admixture Pharmacy Services, Inc. (CAPS®) will present its new quality assurance program requiring 100 percent release testing of all of its compounded drugs and other products at this year's American Society of Health-System Pharmacists (ASHP) 51st Midyear Clinical Meeting.
From Dec. 5-7 in the Mandalay Bay Convention Center in Las Vegas, CAPS representatives will be at booth #2413 to discuss the company's Test, Hold and Release (THR(SM)) program, which is designed to ensure that every compounded drug batch from CAPS' 503B outsourcing facilities meets the new standards for cGMP release testing for sterility, potency, and endotoxin testing prior to release and shipment. CAPS also offers a Certificate of Release for each batch to give customers peace of mind.
"Our existing high quality standards are strengthened with THR implementation, which requires 100 percent release testing on all of our products," said Mike Koch, Senior Vice President, CAPS Professional Services. "When it comes to patient safety and the reputation of our customers, we believe that THR for every batch is the only way to assure the level of quality that's demanded by pharmacists and clinicians to enhance patient outcomes."
CAPS was among the first outsourcing admixture pharmacies in the nation to adopt release testing.
"CAPS is at the forefront of helping hospitals and surgery centers navigate through the new compounding regulatory environment," Koch said. "Our goal is to provide our customers with programs such as THR and consultative services to help them focus on improving patient care."
A market leader in customized Parenteral Nutrition (PN) delivery and provider of quality sterile compounding services for the past 25 years, CAPS also will feature CAPS Consulting(SM), a new service designed to help hospital pharmacists and pharmacies remain compliant in light of new regulations as a result of the Drug Quality & Security Act. CAPS Consulting offers comprehensive evaluations of pharmacies, assesses compliance readiness, and provides recommendations and training.
CAPS is the nation's largest network of outsourcing admixture pharmacies. A pioneer in the outsourcing of CSPs, CAPS was founded in 1991, and delivers high-quality, same-day, admixture services and solutions to hospitals and outpatient facilities across the nation. CAPS has two 503B Outsourcing Facilities that are registered with the FDA to provide anticipatory compounding services. CAPS also has 22 state licensed 503A regional pharmacies that dispense labeled, patient-specific prescriptions including PN and chemotherapy. To learn more, visit www.capspharmacy.com.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 56,000 employees in more than 60 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.
Central Admixture Pharmacy Services, Inc.
Dec. 3, 2016 12:15 PM EST Reads: 1,481
Dec. 3, 2016 12:00 PM EST Reads: 720
Dec. 3, 2016 12:00 PM EST Reads: 926
Dec. 3, 2016 11:45 AM EST Reads: 672
Dec. 3, 2016 11:45 AM EST Reads: 440
Dec. 3, 2016 11:30 AM EST Reads: 2,064
Dec. 3, 2016 11:30 AM EST Reads: 820
Dec. 3, 2016 11:15 AM EST Reads: 1,624
Dec. 3, 2016 10:45 AM EST Reads: 791
Dec. 3, 2016 10:45 AM EST Reads: 2,136
Dec. 3, 2016 09:30 AM EST Reads: 826
Dec. 3, 2016 09:30 AM EST Reads: 3,925
"We are a modern development application platform and we have a suite of products that allow you to application release automation, we do version control, and we do application life cycle management," explained Flint Brenton, CEO of CollabNet, in this SYS-CON.tv interview at DevOps at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Dec. 3, 2016 09:15 AM EST Reads: 698
What happens when the different parts of a vehicle become smarter than the vehicle itself? As we move toward the era of smart everything, hundreds of entities in a vehicle that communicate with each other, the vehicle and external systems create a need for identity orchestration so that all entities work as a conglomerate. Much like an orchestra without a conductor, without the ability to secure, control, and connect the link between a vehicle’s head unit, devices, and systems and to manage the ...
Dec. 3, 2016 09:00 AM EST Reads: 451
Application transformation and DevOps practices are two sides of the same coin. Enterprises that want to capture value faster, need to deliver value faster – time value of money principle. To do that enterprises need to build cloud-native apps as microservices by empowering teams to build, ship, and run in production. In his session at @DevOpsSummit at 19th Cloud Expo, Neil Gehani, senior product manager at HPE, discussed what every business should plan for how to structure their teams to delive...
Dec. 3, 2016 08:30 AM EST Reads: 1,356